Among the 20 proteins, seven of them could be protective factors for OS including HSP70 and BCL2, while the other 13 proteins could deteriorate survival outcome of ovarian cancer patients, including MAPK, MEK1, MTOR, NDRG1, BAD, and GSK3α/β. This evidence concerns the gene BCL2 and ovarian carcinoma.